A comparative study of bimatoprost and travoprost: Effect on intraocular pressure and ocular circulation in newly diagnosed glaucoma patients

Ophthalmologica

Volumn 222, Issue 2, 2008, Pages 88-95

  Alagöz, Gürsoy ^a   Gürel, Kamil ^a   Bayer, Atilla ^b   Serin, Didem ^a   Çelebi, Serdal ^a   Kükner, Şahap ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Bimatoprost; Intraocular pressure; Ocular circulation; Travoprost

Indexed keywords

BIMATOPROST; TRAVOPROST;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIASTOLE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; RANDOMIZED CONTROLLED TRIAL; RETINA ARTERY; SYSTOLE; THERAPY EFFECT; TONOMETER; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; AMIDES; BLOOD FLOW VELOCITY; CLOPROSTENOL; DIASTOLE; EYE; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; HEMODYNAMICS; HUMANS; INTRAOCULAR PRESSURE; LIPIDS; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; RETINAL ARTERY; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 39749165123     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112624     Document Type: Article

References (42)

1. Vogel R, Crick RP, Newson RB, et al: Association between intraocular pressure and loss of visual field in chronic simple glaucoma. Br J Ophthalmol 1990;74:3-6.
2. Sommer A: Intraocular pressure and glaucoma. Am J Ophthalmol 1989;107:186-188.
3. Asrani S, Zeimer R, Wilensky J, et al: Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 2000;9:134-142.
4. Mao LK, Stewart WC, Shields MB: Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol 1991;111:51-55.
5. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 1998;126:498-505.
6. Netland PA, Landry T, Sullivan EK, et al: Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001;132:472-484.
7. Brandt JD, VanDenburgh AM, Chen K, et al: Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: a 3-month clinical trial. Ophthalmology 2001;108:1023-1031; discussion 1032.
8. Parrish RK, Palmberg P, Sheu WP: A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 2003;135:688-703.
9. Alexander CL, Miller SJ, Abel SR: Prostaglandin analog treatment of glaucoma and ocular hypertension. Ann Pharmacother 2002;36:504-511.
10. Woodward DF, Krauss AH, Chen J, et al: The pharmacology of bimatoprost (Lumigan). Surv Ophthalmol 2001;45(suppl 4):S337-S345.
11. Higginbotham EJ, Schuman JS, Goldberg I, et al: One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch Ophthalmol 2002;120:1286-1293.
12. Whitcup SM, Cantor LB, VanDenburgh AM, et al: A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension. Br J Ophthalmol 2003;87:57-62.
13. Toris CB, Camras CB, Yablonski ME, et al: Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function. Surv Ophthalmol 1997;41(suppl 2):S69-S75.
14. Brubaker RF: Mechanism of action of bimatoprost (Lumigan). Surv Ophthalmol 2001;45(suppl 4):S347-S351.
15. Cantor LB, WuDunn D, Cortes A, et al: Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension. Surv Ophthalmol 2004;49(suppl 1):S12-S18.
16. Bengtsson B: Aspects of the epidemiology of chronic glaucoma. Acta Ophthalmol Suppl 1981;(146):1-48.
17. Joos KM, Kay MD, Pillunat LE, et al: Effect of acute intraocular pressure changes on short posterior ciliary artery haemodynamics. Br J Ophthalmol 1999;83:33-38.
18. O'Brart DP, de Souza Lima M, Bartsch DU, et al: Indocyanine green angiography of the peripapillary region in glaucomatous eyes by confocal scanning laser ophthalmoscopy. Am J Ophthalmol 1997;123:657-666.
19. Michelson G, Langhans MJ, Harazny J, et al: Visual field defect and perfusion of the juxtapapillary retina and the neuroretinal rim area in primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 1998;236:80-85.
20. Stroman GA, Stewart WC, Golnik KC, et al: Magnetic resonance imaging in patients with low-tension glaucoma. Arch Ophthalmol 1995;113:168-172.
21. Allemann R, Flammer J, Haefliger IO: Vaso-active properties of bimatoprost in isolated porcine ciliary arteries. Klin Monatsbl Augenheilkd 2003;220:161-164.
22. Zeitz O, Matthiessen ET, Wiermann A, et al: Ocular hemodynamics in normal tension glaucoma: effect of bimatoprost. Klin Monatsbl Augenheilkd 2004;221:550-554.
23. Akarsu C, Yilamz S, Tamer P, et al: Effect of bimatoprost on ocular circulation in patients with open-angle glaucoma or ocular hypertension. Graefes Arch Clin Exp Ophthalmol 2004;242:814-818.
24. Allemann R, Flammer J, Haefliger IO: Absence of vasoactive properties of travoprost in isolated porcine ciliary arteries. Klin Monatsbl Augenheilkd 2003;220:152-155.
25. Rankin SJ: Color Doppler imaging of the retrobulbar circulation in glaucoma. Surv Ophthalmol 1999;43(suppl 1):S176-S182.
26. Baxter GM, Williamson TH: Color Doppler imaging of the eye: normal ranges, reproducibility, and observer variation. J Ultrasound Med 1995;14:91-96.
27. Noecker RJ, Earl ML, Mundorf T, et al: Bimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma or ocular hypertension. Adv Ther 2003;20:121-128.
28. Noecker RS, Dirks MS, Choplin NT, et al: A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol 2003;135:55-63.
29. Sherwood M, Brandt J: Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Surv Ophthalmol 2001;45(suppl 4):S361-S368.
30. Galassi F, Sodi A, Renieri G, et al: Effects of timolol and dorzolamide on retrobulbar hemodynamics in patients with newly diagnosed primary open-angle glaucoma. Ophthalmologica 2002;216:123-128.
31. Galassi F, Nuzzaci G, Sodi A, et al: Color Doppler imaging in evaluation of optic nerve blood supply in normal and glaucomatous subjects. Int Ophthalmol 1992;16:273-276.
32. Harris A, Sergott RC, Spaeth GL, et al: Color Doppler analysis of ocular vessel blood velocity in normal-tension glaucoma. Am J Ophthalmol 1994;118:642-649.
33. Spencer JA, Giussani DA, Moore PJ, et al: In vitro validation of Doppler indices using blood and water. J Ultrasound Med 1991;10:305-308.
34. Butt Z, O'Brien C, McKillop G, et al: Color Doppler imaging in untreated high- and normal-pressure open-angle glaucoma. Invest Ophthalmol Vis Sci 1997;38:690-696.
35. Trible JR, Sergott RC, Spaeth GL, et al: Trabeculectomy is associated with retrobulbar hemodynamic changes. A color Doppler analysis. Ophthalmology 1994;101:340-351.
36. Harris A, Joos K, Kay M, et al: Acute IOP elevation with scleral suction: effects on retrobulbar haemodynamics. Br J Ophthalmol 1996;80:1055-1059.
37. Akarsu C, Bilgili YK, Taner P, et al: Short-term effect of latanoprost on ocular circulation in ocular hypertension. Clin Experiment Ophthalmol 2004;32:373-377.
38. Ishii K, Tomidokoro A, Nagahara M, et al: Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans. Invest Ophthalmol Vis Sci 2001;42:2957-2963.
39. Carrillo MM, Nicolela MT: Cystoid macular edema in a low-risk patient after switching from latanoprost to bimatoprost. Am J Ophthalmol 2004;137:966-968.
40. Wand M, Gaudio AR: Cystoid macular edema associated with ocular hypotensive lipids. Am J Ophthalmol 2002;133:403-405.
41. Joyner WL, Gilmore JP: Tissues grafted into the cheek pouch of the hamster;in Baker CH, Nastuk WL (eds): Physical Techniques in Biology and Medicine: Microcirculatory Technology. London, Academic Press, 1986, pp 3-17.
42. Hellberg MR, McLaughlin MA, Sharif NA, et al: Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist. Surv Ophthalmol 2002;47(suppl 1):S13-S33.